ZIM Laboratories Limited (BOM:541400)

ZIM Laboratories Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	20.72	58.38	121.65	172.46	244.35	145.5
Depreciation & Amortization	213.47	192.88	195.23	154.76	172.02	159.99
Other Amortization	6.9	6.9	5.9	4.76	2.67	0.34
Loss (Gain) From Sale of Assets	-23.7	-25.17	-1.98	-4.7	-0.2	-0.57
Asset Writedown & Restructuring Costs	-	-	-	-	6.6	0.03
Stock-Based Compensation	10.66	11.35	13.54	-	-	-
Provision & Write-off of Bad Debts	2.02	5.49	14.07	9.26	7.91	0.55
Other Operating Activities	90.32	85.93	178.78	94.09	70.27	120.41
Change in Accounts Receivable	-155.03	71.28	-89.92	-71.37	26.95	-19.9
Change in Inventory	103.99	-73.05	-52.07	-275.57	215.78	-209.37
Change in Accounts Payable	39.52	161.34	26.33	79.08	-364.66	295.07
Operating Cash Flow	308.86	495.34	411.55	162.78	381.68	492.06
Operating Cash Flow Growth	27.26%	20.36%	152.82%	-57.35%	-22.43%	54.49%

Investing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-551.16	-443.87	-407.98	-739.23	-366.68	-152.25
Sale of Property, Plant & Equipment	53.97	56.17	7.32	5.48	0.2	1.6
Investment in Securities	-261.28	-177.53	0.85	3.13	3.6	-
Other Investing Activities	9.8	1.76	0.53	0.49	0.85	4.94
Investing Cash Flow	-748.68	-563.48	-399.27	-730.13	-362.04	-145.71

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	-	68.39	-	321.55	55.92	-
Long-Term Debt Issued	-	223.34	246.24	281.47	183.53	270.7
Total Debt Issued	456.79	291.73	246.24	603.02	239.45	270.7
Short-Term Debt Repaid	-	-	-25.27	-	-	-273.79
Long-Term Debt Repaid	-	-254.31	-189.02	-146.56	-173.91	-311.56
Lease Payments	-45.44	-39.39	-35.82	-17.24	-19.2	-12.26
Total Debt Repaid	-251.44	-254.31	-214.28	-146.56	-173.91	-585.34
Net Debt Issued (Repaid)	205.35	37.42	31.96	456.45	65.54	-314.64
Issuance of Common Stock	362.24	350.78	-	214.02	-	-
Common Dividends Paid	-	-	-	-0.49	-0.59	-1.68
Other Financing Activities	-109.83	-106.34	-123	-74.64	-59.5	-13.39
Financing Cash Flow	457.77	281.86	-91.05	595.34	5.46	-329.71

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Foreign Exchange Rate Adjustments	3.13	18.03	2.23	3.8	4.9	3.64
Net Cash Flow	21.09	231.75	-76.54	31.8	30	20.28

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	-242.3	51.48	3.57	-576.45	15	339.81
Free Cash Flow Growth	-	1342.31%	-	-	-95.58%	33.92%
Free Cash Flow Margin	-5.86%	1.38%	0.09%	-15.68%	0.38%	10.19%
Free Cash Flow Per Share	-4.72	1.05	0.07	-11.83	0.31	6.97
Levered Free Cash Flow	-308.09	-153.52	-172.13	-669.13	-139.27	240.6
Unlevered Free Cash Flow	-225.63	-78.05	-108.08	-632.37	-108.2	285.4
Free Cash Flow After Leases	-287.74	12.09	-32.25	-593.69	-4.19	327.55

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	128.95	128.95	123	75.14	55.34	79.26
Cash Income Tax Paid	37.34	37.34	-10.76	25.84	71.49	4.29
Change in Working Capital	-11.52	159.58	-115.66	-267.85	-121.93	65.81

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error